Skip to content
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International, Inc. (NASDAQ:DYAI) and VTT have developed a production platform that boasts higher efficiency and lower cost based on Dyadic’s C1, Thermothelomyces heterothallica , expression platform, and are now developing a production method for a SARS-CoV-2 vaccine as discussed in an article on the VTT research...
Boeing's grounded 737 MAX could receive regulatory approval to resume flying in November and enter service by the end of the year, Europe's chief aviation safety regulator said on Friday. "For the first time in year and a half I can say there's an end in sight to work on the MAX," Patrick Ky, Executive Director of the European Union Aviation Safety Agency (EASA), told French aerospace journalists. EASA expects to lift its technical ban "not long" after the U.S. Federal Aviation Administration, probably in November, but national operational clearances needed for individual airlines to resume flying in Europe could take longer, he said....
* Amended Management Transaction actually offers shareholders cash consideration of no more than $0.119 per share vs $0....
Top news and what to watch in the markets on Friday, September 25, 2020....
WALTHAM, Mass. and FLORENCE, Italy, Sept....
If we look at the average annual returns for different asset classes in the last 10 years, gold has been an underperformer as compared to U.S. equities. I strongly believe that gold will likely match the performance of equities or out-perform in the next few years.The Federal Reserve recently announced that it will keep interest rates near-zero levels through fiscal year 2023. This is the key reason to be bullish on gold. Amid intermediate corrections, the hard currency is likely to trend higher as expansionary monetary policies continue and the dollar weakens.It's worth noting that the Fed expanded its balance sheet from $4.2 trillion in February 2020 to $7.0 trillion in September 2020. This is a clear indication of the aggressive expansionary policies likely to support gold.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inflation is ComingRecently, hedge fund manager Stanley Druckenmiller warned that inflation can potentially hit 10%...
Bristol-Myers Squibb (NYSE:BMY) is incredibly cheap. For example, based on earnings estimates, BMY stock trades at just 7.8 times next year's earnings.Source: IgorGolovniov / Shutterstock.com In addition, it has an attractive dividend yield of 3.11%, which is likely to increase soon. I estimate the stock is worth at least $84.47, or 46% more than its present price.And that is after discounting its real worth significantly, to add in a margin of safety. The target price is primarily based on its expected earnings and dividends, its history, and comparisons with its peers.InvestorPlace - Stock Market News, Stock Advice & Trading Tips BMY Stock Earnings and Dividend ExpectationsLast quarter, the company blew away analysts' earnings forecasts. It is likely to do so again this quarter. For example, Bristol Myers was supposed to hit $1.48 earnings per share in the second quarter, according to analysts' average estimates. But the actual EPS came in at...
